Lv41
440 积分 2023-03-19 加入
Open-Label Placebos as Adjunct for the Preventive Treatment of Migraine
2小时前
已完结
Effectiveness of transcranial direct current stimulation and monoclonal antibodies acting on the CGRP as a combined treatment for migraine (TACTIC): Results of a randomized controlled trial
2小时前
已关闭
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine
2小时前
已完结
Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder
2小时前
已完结
OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial
3小时前
已关闭
Advancing multiple sclerosis management in older adults
9天前
已完结
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
9天前
已完结
Rating neurologic impairment in multiple sclerosis
10天前
已完结
Emerging drugs for the treatment of neuromyelitis optica
18天前
已完结
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
25天前
已完结
皖公网安备34019202002308
